Bioxytran, Inc (BIXT) stock
BIXTOTCPharmaceutical PreparationsFiscal year ends December 31
$0.02−0.00 (-3.95%)
Close on Oct 19, 2026Market cap $2.56MP/E –Yield –
Bioxytran statistics
26 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.
Important dates
- Next earnings
- –
- Last ex-dividend date
- No dividends
- Fundamentals through
- Jun 30, 2026
- Share price as of
- –
Share statisticsIndustry
- Shares Change (YoY)
- 4.83%
- 10.9%
- Shares Change (QoQ)
- 1.18%
- 0.48%
- Float
- 71M
- 49M
- Shares Held by Insiders
- 37.8%
- 12.1%
Returns on capitalIndustry
- Return on Assets (ROA)
- -1453.0%
- -40.7%
Financial positionIndustry
- Current Ratio
- 0.03
- 3.30
- Quick Ratio
- 0.03
- 2.40
- Interest Coverage
- -25.47
- -6.35
EfficiencyIndustry
- Profits Per Employee
- -$873.45K
- -$683.67K
- Employee Count
- 4
- 75
Income statement (TTM)Industry
- Pretax Income
- -$3.49M
- -$13.23M
Balance sheetIndustry
- Net Cash (Debt)
- $177.38K
- $16.56M
- Net Cash Per Share
- $0.00
- $0.71
- Equity (Book Value)
- -$4.94M
- $52.23M
- Book Value Per Share
- -$0.04
- $1.50
- Tangible Book Value
- -$5.10M
- $26.10M
- Working Capital
- -$5.10M
- $78.41M
Cash flow (TTM)Industry
Taxes and interestIndustry
- Interest Expense
- $144.90K
- $2.98M
Scores and fair valueIndustry
- Piotroski F-Score
- 5
- 4
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Oct 19, 2026. The S&P 500 is measured by the SPY fund.
| Period | BIXT | S&P 500 | Difference | BIXT per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | +4.6% | +0.6% | +4.0 pts | ||
| 3 months | -12.6% | +3.4% | −16.0 pts | ||
| Year to date | -70.5% | +13.3% | −83.8 pts | ||
| 1 year | -65.8% | +16.6% | −82.4 pts | ||
| 3 years | -86.8% | +86.4% | −173.2 pts | -49.1% | +23.1% |
| 5 years | +917.3% | +81.9% | +835.4 pts | +59.0% | +12.7% |
| 10 years | -98.5% | +318.9% | −417.4 pts | -34.3% | +15.4% |
Short interest
Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Sep 30, 2026.
0M BIXT shares were sold short on Sep 30, 2026. At recent volumes it would take 1.0 days to buy them back.
| Settlement date | Shares short | Change | Avg. daily volume | Days to cover |
|---|---|---|---|---|
| Sep 30, 2026 | 3,141 | – | 193,851 | 1.0 |
| Aug 14, 2026 | 130 | – | 183,704 | 1.0 |
| Jul 15, 2026 | 14,999 | -2.0% | 83,220 | 1.0 |
| Jun 30, 2026 | 15,299 | +6.9% | 61,199 | 1.0 |
| Jun 15, 2026 | 14,309 | -0.1% | 142,729 | 1.0 |
| May 29, 2026 | 14,330 | +0.9% | 57,993 | 1.0 |
| May 15, 2026 | 14,198 | +4632.7% | 81,682 | 1.0 |
| Apr 30, 2026 | 300 | -91.4% | 223,293 | 1.0 |
| Apr 15, 2026 | 3,506 | -98.4% | 460,206 | 1.0 |
| Mar 31, 2026 | 220,491 | +73397.0% | 1,093,413 | 1.0 |
| Mar 13, 2026 | 300 | -97.1% | 1,769,827 | 1.0 |
| Feb 27, 2026 | 10,300 | +2418.3% | 481,876 | 1.0 |
Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.
See a number that looks wrong?